SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-458926
Filing Date
2012-11-08
Accepted
2012-11-08 07:35:55
Documents
3
Period of Report
2012-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d433398d8k.htm 8-K 14535
2 SAGENT PHARMACEUTICALS, INC. PRESS RELEASE, DATED NOVEMBER 8, 2012 d433398dex991.htm EX-99.1 195696
3 GRAPHIC g433398g71g84.jpg GRAPHIC 27889
  Complete submission text file 0001193125-12-458926.txt   250099
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 121188441
SIC: 2834 Pharmaceutical Preparations